PFBT
NKTR icon

Parkside Financial Bank & Trust’s Nektar Therapeutics NKTR Stock Holding History

Parkside Financial Bank & Trust’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.74K Buy
+52
New +$2.96K ﹤0.01% 1914
2022
Q4 		– Sell
-10
Closed – – 2034
2022
Q3 		$0 Sell
10
-91
-90% -$5.41K ﹤0.01% 1893
2022
Q2 		$6K Buy
101
+32
+46% +$2.02K ﹤0.01% 1177
2022
Q1 		$6K Buy
69
+12
+21% +$1.78K ﹤0.01% 1231
2021
Q4 		$12K Buy
57
+56
+5,600% +$12.1K ﹤0.01% 966
2021
Q3 		$0 Sell
1
-3
-75% -$721 ﹤0.01% 1818
2021
Q2 		$1K Buy
4
+1
+33% +$277 ﹤0.01% 1646
2021
Q1 		$1K Buy
+3
New +$934 ﹤0.01% 1622
2020
Q4 		– Sell
-3
Closed -$1K – 1649
2020
Q3 		$1K Sell
3
-1
-25% -$315 ﹤0.01% 1383
2020
Q2 		$1K Sell
4
-2
-33% -$624 ﹤0.01% 1348
2020
Q1 		$1K Buy
6
+4
+200% +$1.24K ﹤0.01% 1294
2019
Q4 		$1K Sell
2
-1
-33% -$290 ﹤0.01% 1435
2019
Q3 		$1K Sell
3
-1
-25% -$367 ﹤0.01% 1401
2019
Q2 		$2K Buy
4
+1
+33% +$501 ﹤0.01% 1194
2019
Q1 		$2K Buy
3
+1
+50% +$593 ﹤0.01% 1184
2018
Q4 		$1K Buy
2
+1
+100% +$604 ﹤0.01% 1264
2018
Q3 		$1K Hold
1
– – ﹤0.01% 1320
2018
Q2 		$1K Hold
1
– – ﹤0.01% 1303
2018
Q1 		$2K Sell
1
-5
-83% -$6.44K ﹤0.01% 1034
2017
Q4 		$5K Hold
6
– – ﹤0.01% 857
2017
Q3 		$2K Hold
6
– – ﹤0.01% 993
2017
Q2 		$2K Hold
6
– – ﹤0.01% 1001
2017
Q1 		$2K Hold
6
– – ﹤0.01% 982
2016
Q4 		$1K Buy
+6
New +$1.22K ﹤0.01% 1159

Other funds holding NKTR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Parkside Financial Bank & Trust's NKTR Position: Q1 2026 in Review

Parkside Financial Bank & Trust opened a new position in Nektar Therapeutics (NKTR) in Q1 2026: 52 shares worth $3.74K. The stake represents ﹤0.01% of the portfolio and ranks #1914 among its holdings. This is a return to the name: Parkside Financial Bank & Trust previously reported a position in NKTR as recently as Q3 2022.

Parkside Financial Bank & Trust first reported a position in NKTR in Q4 2016 and has held it in 24 quarters since. The position peaked at $12K in Q4 2021. 215 funds tracked by Wall St. Rank hold NKTR as of Q1 2026.

  • Parkside Financial Bank & Trust held 52 shares of Nektar Therapeutics worth $3.74K as of Q1 2026.
  • Nektar Therapeutics was a new Parkside Financial Bank & Trust position in Q1 2026.
  • Nektar Therapeutics made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q1 2026, its #1914 holding.
  • Parkside Financial Bank & Trust first reported a position in Nektar Therapeutics in Q4 2016 and has held it in 24 quarters since.
  • Parkside Financial Bank & Trust's Nektar Therapeutics position peaked at $12K in Q4 2021.
  • 215 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q1 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q1 2026, filed 13 May 2026.